On 3 June, the Commission will open the third request period for joint scientific consultations (JSCs) for 2026. Eligible applicants include developers of medicinal products, as well as medical devices classified as Class IIb or III and in vitro diagnostic devices classified as Class D.

The application window runs from 3 June to 1 July 2026. Requests must be submitted through the HTA IT Platform by 1 July 2026.